FDA puts partial hold on clinical trials of AbbVie's cancer drug
March 19, 2019 at 09:01 AM EDT
AbbVie Inc said on Tuesday the U.S. Food and Drug Administration placed a partial clinical hold on all trials of its cancer treatment Venclexta for multiple myeloma.